Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |